Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

Por Steeghs, Neeltje, Gelderblom, Hans, Wessels, Judith, Eskens, Ferry A. L. M., de Bont, Natasja, Nortier, Johan W. R., Guchelaar, Henk-Jan
Publicado em 2009

Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered

Por Bijlsma, Rhodé M, Bredenoord, Annelien L, Gadellaa-Hooijdonk, Christa G, Lolkema, Martijn PJ, Sleijfer, Stefan, Voest, Emile E, Ausems, Margreet GEM, Steeghs, Neeltje
Publicado no Eur J Hum Genet (2016)

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

Por Verboom, Michiel C., Ouwerkerk, Jan, Steeghs, Neeltje, Lutjeboer, Jacob, Martijn Kerst, J., van der Graaf, Winette T. A., Reyners, Anna K. L., Sleijfer, Stefan, Gelderblom, Hans
Publicado no Clin Sarcoma Res (2017)

Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube canc...

Por van der Noll, Ruud, Marchetti, Serena, Steeghs, Neeltje, Beijnen, Jos H, Mergui-Roelvink, Marja W J, Harms, Emmy, Rehorst, Harriet, Sonke, Gabe S, Schellens, Jan H M
Publicado no Br J Cancer (2015)

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib

Por Steeghs, Neeltje, Mathijssen, Ron H. J., Wessels, Judith A. M., de Graan, Anne-Joy, van der Straaten, Tahar, Mariani, Mariangela, Laffranchi, Bernard, Comis, Silvia, de Jonge, Maja J. A., Gelderblom, Hans, Guchelaar, Henk-Jan
Publicado em 2010

Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662

Por Yu, Huixin, Steeghs, Neeltje, Kloth, Jacqueline S L, de Wit, Djoeke, van Hasselt, J G Coen, van Erp, Nielka P, Beijnen, Jos H, Schellens, Jan H M, Mathijssen, Ron H J, Huitema, Alwin D R
Publicado no Br J Clin Pharmacol (2015)

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded...

Por de Leng, Wendy W. J., Gadellaa-van Hooijdonk, Christa G., Barendregt-Smouter, Françoise A. S., Koudijs, Marco J., Nijman, Ies, Hinrichs, John W. J., Cuppen, Edwin, van Lieshout, Stef, Loberg, Robert D., de Jonge, Maja, Voest, Emile E., de Weger, Roel A., Steeghs, Neeltje, Langenberg, Marlies H. G., Sleijfer, Stefan, Willems, Stefan M., Lolkema, Martijn P.
Publicado no PLoS One (2016)

Implementation of a Multicenter Biobanking Collaboration for Next‐Generation Sequencing‐Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies

Por Bins, Sander, Cirkel, Geert A., Gadellaa‐Van Hooijdonk, Christa G., Weeber, Fleur, Numan, Isaac J., Bruggink, Annette H., van Diest, Paul J., Willems, Stefan M., Veldhuis, Wouter B., van den Heuvel, Michel M., de Knegt, Rob J., Koudijs, Marco J., van Werkhoven, Erik, Mathijssen, Ron H.J., Cuppen, Edwin, Sleijfer, Stefan, Schellens, Jan H.M., Voest, Emile E., Langenberg, Marlies H.G., de Jonge, Maja J.A., Steeghs, Neeltje, Lolkema, Martijn P.
Publicado no Oncologist (2016)